Search

Your search keyword '"Gómez-Puerta, José A"' showing total 432 results

Search Constraints

Start Over You searched for: Author "Gómez-Puerta, José A" Remove constraint Author: "Gómez-Puerta, José A"
432 results on '"Gómez-Puerta, José A"'

Search Results

2. Autoimmune and Rheumatic Diseases and Sexuality

3. Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis

4. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide

5. OMERACT systemic lupus erythematosus domain survey

13. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

14. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases

15. Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas

17. Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients.

18. Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.

19. Teachers' Beliefs about Diversity: An Analysis from a Personal and Professional Perspective

20. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

28. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

29. Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

31. O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort

37. LP-149 Latin-American systemic lupus erythematosus clusters

38. LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort

39. LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort

45. Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

46. OA06 Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions

47. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

Catalog

Books, media, physical & digital resources